Page 15 - AN-3-4

Advanced Neurology LBD prevalence and incidence in India

(DLB). HRB Open Res. 2022;5:57. aging study in india-diagnostic assessment of dementia.
J Am Geriatr Soc. 2020;68(S3):S3-4.
doi: 10.12688/hrbopenres.13590.2
doi: 10.1111/jgs.16740
42. Nichols E, Steinmetz JD, Vollset SE, et al. Estimation of
the global prevalence of dementia in 2019 and forecasted 47. D’Antonio F, Kane JP, Ibañez A, et al. Dementia with
prevalence in 2050: An analysis for the Global Burden of lewy bodies research consortia: A global perspective
Disease Study 2019. Lancet Public Health. 2022;7(2):e105-25. from the ISTAART lewy body dementias professional
interest Area working group. Alzheimers Dement (Amst).
doi: 10.1016/S2468-2667(21)00249-8 2021;13(1):e12235.
43. Livingston G, Huntley J, Sommerlad A, et al. Dementia doi: 10.1002/dad2.12235
prevention, intervention, and care: 2020 Report of the lancet
commission. Lancet. 2020;396(10248):413-446. 48. Camargo CH, Retzlaff G, Justus FF, Resende M. Patients
with dementia syndrome in public and private services in
doi: 10.1016/S0140-6736(20)30367-6 southern Brazil. Dement Neuropsychol. 2015;9(1):64-70.
44. Malhotra C, Do YK. Socio-economic disparities in doi: 10.1590/s1980-57642015dn91000010
health system responsiveness in India. Health Policy Plan.
2013;28(2):197-205. 49. Surendranathan A, Kane J, Bentley A, et al. Introduction of
an assessment toolkit associated with increased rate of DLB
doi: 10.1093/heapol/czs051 diagnosis. Alzheimers Res Ther. 2021;13(1):50.
45. Deal J, Rojas JC. Visual impairment as a modifiable risk doi: 10.1186/s13195-021-00786-8
factor in dementia prevention and management. JAMA 50. O’Brien JT, McKeith IG, Thomas AJ, et al. Introduction of a
Neurol. 2022;79(6):542-543.
management toolkit for lewy body dementia: A pilot cluster-
doi: 10.1001/jamaneurol.2022.0092 randomized trial. Mov Disord. 2021;36(1):143-151.
46. Lee J, Dey AB. Introduction to LASI-DAD: The longitudinal doi: 10.1002/mds.28282

Volume 3 Issue 4 (2024) 9 doi: 10.36922/an.4098